Worth saying clearly: the ICMR-NIN Dietary Guidelines for Indians (2024) rightly emphasise building a varied, balanced diet first
tirzepatide, 2,525) and 85,018 patients with obesity in the non-AOM cohort
Top performers highlighted in bold
Current evidence suggests that both brand-name and high-quality compounded versions can provide anti-inflammatory benefits that extend beyond simple weight loss effects
It was built for scale
the cohort included 13,204 GLP-1 RA users and 13,204 nonusers.The researchers observed associations for GLP-1 RA use with lower risks for stroke/transient ischemic attack, pulmonary embolism, venous thromboembolism, emergency department visits, and mortality (hazard ratios, 0.87, 0.69, 0.83, 0.79, and 0.56, respectively)."As an obesity medicine physician scientist who regularly cares for patients with complex inflammatory conditions, this study reinforces what many of us have suspected clinically -- that the benefits of GLP-1 receptor agonists extend well beyond blood sugar control and weight loss and may fundamentally alter the disease trajectory for some of our highest-risk patients," Fatima Cody Stanford, M.D., M.P.H., member of the American Heart Association Lifestyle and Cardiometabolic Council, said in a statement.Abstract/Full TextMore Information.Sign up for our weekly HealthDay newsletter
